10x Genomics and Fred Hutch partner on cancer technologies

10x Genomics has entered into a multi-project research agreement with Fred Hutch for advancing single cell as well as spatial platforms in solid tumours and blood cancers. The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic malignancies. The team will deploy the Flex Apex and Xenium platforms, with future plans to incorporate the Atera platform. Credit: Gorodenkoff/Shutterstock.com. 10x Genomics has entered into a multi-project research agreement with Fred Hutchinson Cancer Center (Fred Hutch) for advancing single cell as well as spatial platforms in solid tumours and blood cancers. The initiative represents the…

Source: Pharmaceutical Technology